Abstract
Background: Acute Kidney Injury (AKI) commonly occurs in patients with decompensated cirrhosis. Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) could help in discriminating between different etiologies of AKI. The aim of this study was to investigate the use of uNGAL in: a) differential diagnosis of AKI; b) predicting the response to terlipressin and albumin in patients with Hepatorenal Syndrome (HRS-AKI); c) predicting in-hospital and 90-day mortality.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
